{"id":47527,"date":"2017-08-29T10:18:56","date_gmt":"2017-08-29T14:18:56","guid":{"rendered":"https:\/\/asweetlife.org\/?p=47527"},"modified":"2017-08-29T10:18:56","modified_gmt":"2017-08-29T14:18:56","slug":"at-eli-lilly-headquarters-diabetes-advocates-will-demonstrate-for-affordable-insulin","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=47527","title":{"rendered":"At Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin"},"content":{"rendered":"

The astronomical costs of insulin made by three pharma giants Eli Lilly, Novo Nordisk, and Sanofi, who almost completely dominate the market have continued to increase<\/a>, with no end in sight. Millions of people with diabetes in the U.S. have no option but to pay the high prices set by pharma companies because the alternative is death<\/a>.<\/p>\n

With each price increase, desperation, too, increases. And in mid-March of this year, just weeks after holding an \u2018Insulin Pricing and Access Workshop\u2019 with patient advocates, Eli Lilly again raised the price<\/a>\u00a0of their most lucrative insulins, Humalog and Humilin, by 7.8%.<\/p>\n

The diabetes community has watched in agony<\/a> as the prices of insulin have increased again and again. The list price of Humalog was $274.70 per a vial as of May 2017. That is a\u00a0price increase<\/a>\u00a0of 1123% since June 1996. Insulin manufacturers work hard to keep the cost of insulin production a\u00a0tightly-guarded secret, but we know that prices of insulin in the U.S. are likely\u00a0set at hundreds of times higher\u00a0than the amount it takes to make the drug.<\/p>\n

People living with diabetes\u00a0in the U.S. and around the world have died due to an\u00a0inability to afford<\/a>\u00a0insulin. Physicians report seeing more and more insulin-deprived patients in crisis\u00a0coming into emergency rooms<\/a>. More advocates and politicians are becoming vocal about the need for affordable insulin as the problem hits the middle class harder. Senator Bernie Sanders asked the Department of Justice and the Federal Trade Commission to investigate the big three<\/a> for price collusion, and the price increases have been called\u00a0\u201cprice gouging, plain and simple<\/a>\u201d by Senator Jon Tester.<\/p>\n

Frustration and even disgust about unaffordable insulin has been expressed in many ways:\u00a0online<\/a>, in\u00a0meetings<\/a>\u00a0with these companies, in numerous\u00a0blog posts<\/a>, and more. The diabetes community as a whole has been\u00a0talking to Lilly\u00a0and others<\/a>\u00a0about these issues for a long time, so Eli Lilly, Sanofi, and Novo Nordisk know that people are outraged, suffering and\u00a0dying<\/a>\u00a0because insulin costs too much.<\/p>\n

Our concerns have not been taken seriously enough. Hosting forums with advocates or creating limited charity programs is not enough. Taking our concerns seriously means making insulin affordable and not taking advantage of desperate people. It means putting an end to price gouging because high prices are putting people in danger.<\/p>\n

The advocacy group T1International believes that patient-led movements<\/a> will be the strongest force in bringing about a change, which is why we are demonstrating in front of Eli Lilly<\/a>\u00a0headquarters in Indianapolis on September 9th<\/sup>. People with diabetes are demanding better.<\/p>\n

People with diabetes are asking Eli Lilly for three things:<\/p>\n

    \n
  1. Be transparent about how much it costs to make one vial of Humalog insulin<\/li>\n
  2. Be transparent about your profits from each vial<\/li>\n
  3. Stop the immoral act of price-gouging and lower the price of insulin<\/li>\n<\/ol>\n

     <\/p>\n

    We believe strongly that if people and their representatives demand it, these companies will provide transparency and lower prices because Eli Lilly, Novo Nordisk, and Sanofi\u2019s business models depend on government regulations and bulk purchases of their products. This demonstration can amplify our cries and raise the public’s awareness of the exorbitant insulin prices.<\/p>\n

    The\u00a0location of our partner organizations,\u00a0People of Faith for Access to Medicines<\/a> and\u00a0Public Citizen<\/a>\u00a0in Indiana, makes Lilly’s headquarters a natural place for our first demonstration, but Novo Nordisk and Sanofi are just as much a part of the problem as Eli Lilly, and all three must be held accountable.<\/p>\n

    If you cannot attend the demonstration at Lilly, you can still take action. On September 8th<\/sup>, in solidarity with the protesters, we will also be holding an\u00a0online day of action<\/a>\u00a0about insulin pricing \u2013 addressing all three players in the insulin market.<\/p>\n

    Are you planning to attend the Indiana demonstration or want to stay up to date on our plans? Join the Facebook event<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

    …<\/p>\n","protected":false},"author":67,"featured_media":47532,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1429],"tags":[],"yoast_head":"\nAt Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin | ASweetLife<\/title>\n<meta name=\"description\" content=\"The astronomical costs of insulin made by three pharma giants Eli Lilly, Novo Nordisk, and Sanofi, who almost completely dominate the market have continued to increase, with no end in sight.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=47527\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elizabeth Pfiester\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=47527\",\"url\":\"https:\/\/asweetlife.org\/?p=47527\",\"name\":\"At Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin | ASweetLife\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47527#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47527#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/08\/at-eli-lilly-headquarters-diabetes-advocates-will-demonstrate-for-affordable-insulin.png\",\"datePublished\":\"2017-08-29T14:18:56+00:00\",\"dateModified\":\"2017-08-29T14:18:56+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/275a44f679b71a9378f950c1f2c58b87\"},\"description\":\"The astronomical costs of insulin made by three pharma giants Eli Lilly, Novo Nordisk, and Sanofi, who almost completely dominate the market have continued to increase, with no end in sight.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47527#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=47527\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=47527#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/08\/at-eli-lilly-headquarters-diabetes-advocates-will-demonstrate-for-affordable-insulin.png\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/08\/at-eli-lilly-headquarters-diabetes-advocates-will-demonstrate-for-affordable-insulin.png\",\"width\":1124,\"height\":1125,\"caption\":\"At Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=47527#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"At Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/275a44f679b71a9378f950c1f2c58b87\",\"name\":\"Elizabeth Pfiester\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a4c525e46e39de364ffcee990daf8a7d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a4c525e46e39de364ffcee990daf8a7d?s=96&d=mm&r=g\",\"caption\":\"Elizabeth Pfiester\"},\"description\":\"Elizabeth Pfiester has lived with Type 1 diabetes for over 20 years. Early on, she found her passions of education and humanitarian work, which took her to the London, where she received a Master\u2019s degree in International Development and Humanitarian Emergencies at the London School of Economics and Political Science. Elizabeth started www.t1international.com last year to create a space to easily navigate global diabetes resources, organizations, and existing literature about care, policy, and treatment in places where Type 1 diabetics are often forgotten. Since its inception, she has been conducting interviews and writing articles; she now has readers from over 80 countries.\",\"url\":\"https:\/\/asweetlife.org\/?author=67\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"At Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin | ASweetLife","description":"The astronomical costs of insulin made by three pharma giants Eli Lilly, Novo Nordisk, and Sanofi, who almost completely dominate the market have continued to increase, with no end in sight.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=47527","twitter_misc":{"Written by":"Elizabeth Pfiester","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=47527","url":"https:\/\/asweetlife.org\/?p=47527","name":"At Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin | ASweetLife","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=47527#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=47527#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/08\/at-eli-lilly-headquarters-diabetes-advocates-will-demonstrate-for-affordable-insulin.png","datePublished":"2017-08-29T14:18:56+00:00","dateModified":"2017-08-29T14:18:56+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/275a44f679b71a9378f950c1f2c58b87"},"description":"The astronomical costs of insulin made by three pharma giants Eli Lilly, Novo Nordisk, and Sanofi, who almost completely dominate the market have continued to increase, with no end in sight.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=47527#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=47527"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=47527#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/08\/at-eli-lilly-headquarters-diabetes-advocates-will-demonstrate-for-affordable-insulin.png","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2017\/08\/at-eli-lilly-headquarters-diabetes-advocates-will-demonstrate-for-affordable-insulin.png","width":1124,"height":1125,"caption":"At Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=47527#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"At Eli Lilly Headquarters, Diabetes Advocates Will Demonstrate For Affordable Insulin"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/275a44f679b71a9378f950c1f2c58b87","name":"Elizabeth Pfiester","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a4c525e46e39de364ffcee990daf8a7d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a4c525e46e39de364ffcee990daf8a7d?s=96&d=mm&r=g","caption":"Elizabeth Pfiester"},"description":"Elizabeth Pfiester has lived with Type 1 diabetes for over 20 years. Early on, she found her passions of education and humanitarian work, which took her to the London, where she received a Master\u2019s degree in International Development and Humanitarian Emergencies at the London School of Economics and Political Science. Elizabeth started www.t1international.com last year to create a space to easily navigate global diabetes resources, organizations, and existing literature about care, policy, and treatment in places where Type 1 diabetics are often forgotten. Since its inception, she has been conducting interviews and writing articles; she now has readers from over 80 countries.","url":"https:\/\/asweetlife.org\/?author=67"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47527"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/67"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=47527"}],"version-history":[{"count":8,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47527\/revisions"}],"predecessor-version":[{"id":47536,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47527\/revisions\/47536"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/47532"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=47527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=47527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=47527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}